Biomerieux SA (BIOX.PA)
BIOX.PA on Paris Stock Exchange
71.80EUR
14 Aug 2018
71.80EUR
14 Aug 2018
Change (% chg)
€0.70 (+0.98%)
€0.70 (+0.98%)
Prev Close
€71.10
€71.10
Open
€71.50
€71.50
Day's High
€72.70
€72.70
Day's Low
€71.50
€71.50
Volume
61,513
61,513
Avg. Vol
117,395
117,395
52-wk High
€82.20
€82.20
52-wk Low
€59.00
€59.00
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2017 | Dec '17 | 1,153.90 | 1.162 |
| Jun '17 | 1,134.30 | 0.854 | |
| FY 2016 | Dec '16 | 1,102.40 | 0.794 |
| Jun '16 | 1,000.80 | 0.723 |
*Note: Units in Millions ofEuro
**Note: Units in Euro
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 1 | 1,219.30 | 1,219.30 | 1,219.30 | 1,237.50 |
| Quarter Ending Jun-19 | 1 | 1,234.50 | 1,234.50 | 1,234.50 | -- |
| Year Ending Dec-18 | 11 | 2,397.21 | 2,435.00 | 2,364.36 | 2,525.70 |
| Year Ending Dec-19 | 11 | 2,582.13 | 2,658.00 | 2,529.80 | 2,755.26 |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | 1 | 0.93 | 0.93 | 0.93 | 1.07 |
| Quarter Ending Jun-19 | 1 | 1.10 | 1.10 | 1.10 | -- |
| Year Ending Dec-18 | 12 | 1.98 | 2.22 | 1.82 | 2.13 |
| Year Ending Dec-19 | 12 | 2.32 | 2.64 | 2.09 | 2.46 |
| LT Growth Rate (%) | 2 | 12.95 | 13.40 | 12.50 | 13.35 |
Sales and Profit Figures in Euro (EUR);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | 42.79 | 32.29 | 32.76 | |
| P/E High - Last 5 Yrs. | 39.24 | 40.75 | 45.45 | |
| P/E Low - Last 5 Yrs. | 18.33 | 20.24 | 24.26 | |
| Beta | 0.36 | 0.79 | 0.89 | |
| Price to Sales (TTM) | 3.73 | 7.41 | 5.75 | |
| Price to Book (MRQ) | 5.10 | 13.11 | 5.47 | |
| Price to Tangible Book (MRQ) | 11.47 | 26.49 | 7.04 | |
| Price to Cash Flow (TTM) | 22.97 | 21.83 | 23.29 | |
| % Owned Institutions | -- | 5.00 | 2.21 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | 0.47 | 1.03 | 1.51 | |
| Dividend Yield - 5 Year Avg | 1.03 | 1.20 | 1.52 | |
| Dividend 5 Year Growth Rate | 0.41 | 16.81 | 5.22 | |
| Payout Ratio(TTM) | 20.31 | 30.05 | 43.78 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 13.34 | 8.45 | 8.01 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 10.06 | 2.05 | 5.64 | |
| Sales - 5 Yr. Growth Rate | 8.06 | 8.76 | 10.18 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 18.11 | 48.69 | 20.61 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 42.93 | -- | -- | |
| EPS - 5 Yr. Growth Rate | 2.55 | 19.28 | 10.66 | |
| Capital Spending - 5 Yr. Growth Rate | 17.94 | 8.74 | 15.34 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 1.18 | 2.38 | 2.22 |
| Current Ratio (MRQ) | 1.82 | 3.12 | 3.03 |
| LT Debt to Equity (MRQ) | 23.01 | 30.36 | 12.51 |
| Total Debt to Equity (MRQ) | 31.38 | 37.07 | 16.85 |
| Interest Coverage (TTM) | 10.28 | 16.04 | 32.63 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 53.06 | 58.91 | 54.37 | |
| Gross Margin - 5 Yr. Avg. | 51.19 | 58.61 | 52.17 | |
| EBITD Margin (TTM) | 20.93 | -- | -- | |
| EBITD - 5 Yr. Avg | 20.41 | 23.26 | 10.65 | |
| Operating Margin (TTM) | 13.41 | 17.77 | 4.33 | |
| Operating Margin - 5 Yr. Avg. | 13.13 | 15.86 | 6.06 | |
| Pre-Tax Margin (TTM) | 12.38 | 17.43 | 5.18 | |
| Pre-Tax Margin - 5 Yr. Avg. | 12.22 | 16.05 | 6.49 | |
| Net Profit Margin (TTM) | 8.72 | 13.36 | 1.48 | |
| Net Profit Margin - 5 Yr. Avg. | 8.13 | 11.19 | 2.77 | |
| Effective Tax Rate (TTM) | 29.58 | 22.63 | 23.11 | |
| Effective Tax Rate - 5 Yr. Avg. | 33.49 | 28.75 | 23.97 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 228,095 | 26,752,260 | 860,433,555 | |
| Net Income/Employee (TTM) | 19,886 | 3,194,677 | 101,214,060 | |
| Receivable Turnover (TTM) | 5.23 | 5.09 | 5.87 | |
| Inventory Turnover (TTM) | 2.67 | 3.16 | 3.41 | |
| Asset Turnover (TTM) | 0.79 | 0.78 | 0.94 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | 6.86 | 10.47 | 11.13 | |
| Return on Assets - 5 Yr. Avg. | 6.14 | 9.08 | 12.40 | |
| Return on Investment (TTM) | 8.88 | 13.92 | 14.61 | |
| Return on Investment - 5 Yr. Avg. | 8.26 | 11.76 | 16.13 | |
| Return on Equity (TTM) | 12.39 | 16.77 | 16.33 | |
| Return on Equity - 5 Yr. Avg. | 10.90 | 14.18 | 17.39 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 7.05 | 9.82 | 8.06 |
| EPS (TTM) % | 62.50 | 3.04 | 2.55 |
| Dividend % | 0.00 | 0.00 | 0.41 |
Note: Units in Millions of US Dollars
Performance for Biomerieux SA
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 3.11 | -1.63 | 99 | 54 |
| 13 Week | 12.46 | 7.95 | 99 | 69 |
| 26 Week | 33.50 | 27.90 | 99 | 58 |
| 52 Week | 58.38 | 32.38 | 99 | 34 |
| YTD | 49.11 | 35.27 | 99 | 33 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
- BRIEF-Biomerieux Q1 Sales Up 3.4 Percent 587 Million Euros
- BRIEF-Biomerieux Acquires Astute Medical Inc. For About $90 Mln In Cash
- French and Benelux stocks-Factors to watch on April 5
- UPDATE 2-European shares dip as earnings fail to dispel US rate worries
- European shares dip as earnings fail to dispel Wall Street gloom
Institutional Holders
| % Shares Owned: | 18.36% |
| # of Holders: | 221 |
| Total Shares Held: | 21,735,642 |
| 3 Mo. Net Change: | -6,318 |
| # New Positions: | 8 |
| # Closed Positions: | 14 |
| # Increased Positions: | 71 |
| # Reduced Positions: | 63 |
| # Net Buyers: | 8 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.